SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 2762.82 millions for the December 2023 quarter as against Rs. 3024.05 millions during the year-ago period.The Company's Net profit for the December 2023 quarter have declined marginally to Rs. 216.55  millions as against Rs. 292.19 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 613.57 millions from 642.68 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 2762.82 3024.05 -8.64 8455.88 8614.75 -1.84 11519.57 9880.90 16.58
Other Income 71.14 83.58 -14.88 200.64 232.93 -13.86 332.82 424.97 -21.68
PBIDT 613.57 642.68 -4.53 1975.20 1890.42 4.48 2553.73 2362.02 8.12
Interest 210.54 223.83 -5.94 625.76 703.44 -11.04 921.66 955.45 -3.54
PBDT 403.03 418.85 -3.78 1349.44 1186.98 13.69 1365.59 1389.65 -1.73
Depreciation 135.56 154.25 -12.12 406.29 480.78 -15.49 573.62 1309.70 -56.20
PBT 267.47 264.60 1.08 943.15 706.20 33.55 791.97 79.95 890.58
TAX 50.92 -27.59 -284.56 255.16 -27.59 -1024.83 367.26 137.05 167.98
Deferred Tax 0.00 0.00 0.00 86.15 0.00 0.00 233.62 -109.17 -314.00
PAT 216.55 292.19 -25.89 687.99 733.79 -6.24 424.71 -57.10 -843.80
Equity 590.87 590.87 0.00 590.87 590.87 0.00 590.87 590.87 0.00
PBIDTM(%) 22.21 21.25 4.50 23.36 21.94 6.45 22.17 23.90 -7.26

Ind-Swift Lab. Share Price

132.00 -13.30 (-9.15%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×